scholarly journals Cost‐Effectiveness of Tenofovir as First‐Line Antiretroviral Therapy in India

2010 ◽  
Vol 50 (3) ◽  
pp. 416-425 ◽  
Author(s):  
Melissa A. Bender ◽  
Nagalingeswaran Kumarasamy ◽  
Kenneth H. Mayer ◽  
Bingxia Wang ◽  
Rochelle P. Walensky ◽  
...  
AIDS ◽  
2011 ◽  
Vol 25 (4) ◽  
pp. 479-492 ◽  
Author(s):  
Andrea L Ciaranello ◽  
Shahin Lockman ◽  
Kenneth A Freedberg ◽  
Michael Hughes ◽  
Jennifer Chu ◽  
...  

AIDS ◽  
2015 ◽  
Vol 29 (10) ◽  
pp. 1247-1259 ◽  
Author(s):  
Andrea L. Ciaranello ◽  
Kathleen Doherty ◽  
Martina Penazzato ◽  
Jane C. Lindsey ◽  
Linda Harrison ◽  
...  

PLoS ONE ◽  
2012 ◽  
Vol 7 (8) ◽  
pp. e42834 ◽  
Author(s):  
Viktor von Wyl ◽  
Valentina Cambiano ◽  
Michael R. Jordan ◽  
Silvia Bertagnolio ◽  
Alec Miners ◽  
...  

2012 ◽  
Vol 12 (1) ◽  
Author(s):  
Joseph Sempa ◽  
Mark Ssennono ◽  
Andreas Kuznik ◽  
Mohammed Lamorde ◽  
Stefanie Sowinski ◽  
...  

Author(s):  
Kubaeva M B ◽  
Gushchina J Sh ◽  
Loskutova E E

  Objective: This study was conducted to evaluate the use of genetic tests, before prescribing drugs to reduce not only the level of side effects but also the costs associated with changing therapy. In this paper, the authors analyze the economic efficiency of HLA*5701 prospective screening of hypersensitivity to abacavir (ABC) in the treatment of HIV-infected patients.Methods: A retrospective study was conducted among HIV-infected patients taking first-line antiretroviral therapy and further, based on the results obtained with the ABC-hypersensitivity reactions, analyzed the costs that affect on healthcare system.Results: In the study group of HIV-infected patients, most of the cases belonged to a young, socially active part of the population. Among the study population of patients (n=637), 171 patients were assigned ABC-containing antiretroviral therapy. An increase in costs was found in 67% of cases when ABC-containing first-line therapy was replaced due to the occurrence of undesirable reactions.Conclusion: The results show that, using this screening, we could reduce the costs associated with replacement therapy


2013 ◽  
Vol 16 (4) ◽  
pp. 552-559 ◽  
Author(s):  
Machaon Bonafede ◽  
Timothy Juday ◽  
Greg Lenhart ◽  
Katy Pan ◽  
Tony Hebden ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document